Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "CH Basel Balavenkatraman KK"

From Bioblast
(Created page with "{{MiPNetLab |MiPNetLab=Chiesi M, Grueninger S |Info=[http://www.oroboros.at/index.php?id=1215 CH_Basel_ChiesiM] }}")
Β 
Β 
(14 intermediate revisions by 5 users not shown)
Line 1: Line 1:
{{MiPNetLab
{{O2k-Network Lab
|MiPNetLab=Chiesi M, Grueninger S
|institution=Investigator II (iTox-PCS) - Novartis Pharma Ltd., WKL-135.3.21
|address=Klybeckstr 191
|area code=4057
|city=Basel
|country=Switzerland
|Contact=Balavenkatraman Kamal Kumar
|MiPNetLab=Grueninger Stephan
|Team previous=Chiesi Michele, Weiss Alexander
|Status=O2k 2007 –
|info=[[IOC106]], [[IOC39]]
|Info=[http://www.oroboros.at/index.php?id=1215 CH_Basel_ChiesiM]
|Info=[http://www.oroboros.at/index.php?id=1215 CH_Basel_ChiesiM]
}}
}}
* Previously CH_Basel_Chiesi M

Latest revision as of 11:39, 14 May 2019

                



CH Basel Balavenkatraman KK

Oroboros O2k-Network

O2k-Network
O2k-Network Lab Investigator II (iTox-PCS) - Novartis Pharma Ltd., WKL-135.3.21
Address Klybeckstr 191, 4057
City Basel
State/Prov
Country Switzerland
Weblink
Contact Balavenkatraman Kamal Kumar
Team Grueninger Stephan
Team previous Chiesi Michele, Weiss Alexander
Status O2k 2007 –
Oroboros Events IOC106, IOC39
Topics


O2k-Publications

update please

O2k-Abstracts

update please

  • Previously CH_Basel_Chiesi M